One new vaccine gene, which researchers say could be designed and developed in a week, can be adapted for the protection of a number of diseases, including Zika and possibly cancer.
Mosquitoes are one of the most common vector-borne, ranging from Zika to Malaria. And Zika cause birth defects in babies. The disease spread throughout America, from Brazil to Puerto Rico now reached the United States.
 |
| Scientists are racing to make a vaccine to fight the virus Zika. (Picture from: http://adf.ly/1dY04S) |
So far raised fierce competition to create a vaccine against Zika. Some of them are now entering clinical trials. A chemical engineer at the Massachusetts Institute of Technology (MIT) Omar Khan hopes that his RNA vaccines will soon follow.
"Things such as Zika or Ebola outbreak recently, we were able to quickly respond within seven days. So where are hard pressed, and we need something safe, we were able to accomplish that," said Khan.
Vaccines that use the RNA messengers to stimulate the immune system. Researchers were able to direct directing these genetic materials of the virus or bacteria to fight any disease-causing organisms, and tied onto a single nanoparticle.
The ideas are old. But changing the vaccine into the cell is not easy, so the MIT researchers have designed it to be as small viruses being targeted. The researchers believe that they may be able to package the RNA vaccines against a number of other diseases.
"So, we are of course interested to know whether these vaccines can be used to treat patients with cancer or even for patients who may be at risk of developing certain cancers. Maybe we can give them the vaccine so that they will not get cancer later in life," says Daniel Anderson of MIT.
So far the new RNA vaccines tested in mice. The researchers have established the company to promote the versatile RNA vaccines when the vaccines are ready available for human. *** [EKA | FROM VARIOUS SOURCES | VOA NEWS]
Note: This blog can be accessed via your smart phone
